Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients.
Kameshima H, Tsuruma T, Kutomi G, Shima H, Iwayama Y, Kimura Y, Imamura M, Torigoe T, Takahashi A, Hirohashi Y, Tamura Y, Tsukahara T, Kanaseki T, Sato N, Hirata K.
Kameshima H, et al. Among authors: kutomi g.
Cancer Sci. 2013 Jan;104(1):124-9. doi: 10.1111/cas.12046. Epub 2012 Dec 16.
Cancer Sci. 2013.
PMID: 23078230
Free PMC article.
Clinical Trial.